Inherited Hypertrabeculation? Genetic and Clinical Insights in Blood Relatives of Genetically Affected Left Ventricular Excessive Trabeculation Patients

Overview

Journal Life (Basel)

Specialty Biology

Date 2025 Feb 26

PMID 40003559

Authors

Balazs Mester

Zoltan Liptak

Kristof Attila Farkas-Suto

Kinga Grebur

Flora Klara Gyulanczi

Alexandra Fabian

Balint Andras Fekete

Tamas Attila Gyorgy

Csaba Bodor

Attila Kovacs

Bela Merkely

Andrea Szucs

Affiliations

Soon will be listed here.

Abstract

Genetically determined left ventricular excessive trabeculation (LVET) has a wide clinical spectrum ranging from asymptomatic subjects to severe heart failure with arrhythmias and thromboembolic events. Unlike other cardiomyopathies, the relatives of LVET patients never reach the spotlight of guidelines and clinical practice, although these family members can be often affected by these conditions. Thus, we aimed to investigate the relatives of LVET by multidimensional analysis, such as genetic testing, ECG and cardiac ultrasound (ECHO). We included 55 blood relatives from the family of 18 LVET patients (male = 27, age = 44 ± 20.8y), who underwent anamnesis registration. With Sanger sequencing, the relatives were classified into genetically positive (GEN-pos) and unaffected (GEN-neg) subgroups. In addition to regular ECG parameters, Sokolow-Lyon Index (SLI) values were calculated. 2D ECHO images were analysed with TomTec Arena, evaluating LV volumetric, functional (EF) and strain parameters. Individuals were categorized into JENNI-pos and JENNI-neg morphological subgroups according to the Jenni LVET ECHO criteria. Family history showed frequent involvement (arrhythmia 61%, stroke 56%, syncope 39%, sudden cardiac death 28%, implanted device 28%), as well as personal anamnesis (subjective symptoms 75%, arrhythmias 44%). ECG and ECHO parameters were within the normal range. In terms of genetics, 78% of families and 38% of relatives carried the index mutation. LV_SLI and QT duration were lower in the GEN-pos group; ECHO parameters were comparable in the subgroups. Morphologically, 33% of the relatives met Jenni-LVET criteria were genetically affected and showed lower LV_EF values. The frequently found genetic, morphological and clinical involvement may indicate the importance of screening and, if necessary, regular follow-up of relatives in the genetically affected LVET population.

References

Haland T, Saberniak J, Leren I, Edvardsen T, Haugaa K . Echocardiographic comparison between left ventricular non-compaction and hypertrophic cardiomyopathy. Int J Cardiol. 2016; 228:900-905. DOI: 10.1016/j.ijcard.2016.11.162. View

Murphy R, Thaman R, Blanes J, Ward D, Sevdalis E, Papra E . Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J. 2004; 26(2):187-92. DOI: 10.1093/eurheartj/ehi025. View

DAmato G, Luxan G, de la Pompa J . Notch signalling in ventricular chamber development and cardiomyopathy. FEBS J. 2016; 283(23):4223-4237. DOI: 10.1111/febs.13773. View

Vergani V, Lazzeroni D, Peretto G . Bridging the gap between hypertrabeculation phenotype, noncompaction phenotype and left ventricular noncompaction cardiomyopathy. J Cardiovasc Med (Hagerstown). 2020; 21(3):192-199. DOI: 10.2459/JCM.0000000000000924. View

Surawicz B, Childers R, Deal B, Gettes L, Bailey J, Gorgels A . AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias.... Circulation. 2009; 119(10):e235-40. DOI: 10.1161/CIRCULATIONAHA.108.191095. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Stacey R, Andersen M, St Clair M, Hundley W, Thohan V . Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR. JACC Cardiovasc Imaging. 2013; 6(9):931-40. DOI: 10.1016/j.jcmg.2013.01.014. View

Petersen S, Jensen B, Aung N, Friedrich M, McMahon C, Mohiddin S . Excessive Trabeculation of the Left Ventricle: JACC: Cardiovascular Imaging Expert Panel Paper. JACC Cardiovasc Imaging. 2023; 16(3):408-425. PMC: 9988693. DOI: 10.1016/j.jcmg.2022.12.026. View

van Waning J, Moesker J, Heijsman D, Boersma E, Majoor-Krakauer D . Systematic Review of Genotype-Phenotype Correlations in Noncompaction Cardiomyopathy. J Am Heart Assoc. 2019; 8(23):e012993. PMC: 6912966. DOI: 10.1161/JAHA.119.012993. View

10.

Chuang M, Gona P, Hautvast G, Salton C, Breeuwer M, ODonnell C . CMR reference values for left ventricular volumes, mass, and ejection fraction using computer-aided analysis: the Framingham Heart Study. J Magn Reson Imaging. 2013; 39(4):895-900. PMC: 3961548. DOI: 10.1002/jmri.24239. View

11.

Mestroni L, Brun F, Spezzacatene A, Sinagra G, Taylor M . GENETIC CAUSES OF DILATED CARDIOMYOPATHY. Prog Pediatr Cardiol. 2015; 37(1-2):13-18. PMC: 4288017. DOI: 10.1016/j.ppedcard.2014.10.003. View

12.

. The Clinical Genome Resource (ClinGen): Advancing genomic knowledge through global curation. Genet Med. 2024; 27(1):101228. DOI: 10.1016/j.gim.2024.101228. View

13.

Gregor Z, Kiss A, Grebur K, Dohy Z, Kovacs A, Merkely B . Characteristics of the right ventricle in left ventricular noncompaction with reduced ejection fraction in the light of dilated cardiomyopathy. PLoS One. 2023; 18(9):e0290981. PMC: 10519585. DOI: 10.1371/journal.pone.0290981. View

14.

Casas G, Rodriguez-Palomares J, Ferreira-Gonzalez I . Left ventricular noncompaction: a disease or a phenotypic trait?. Rev Esp Cardiol (Engl Ed). 2022; 75(12):1059-1069. DOI: 10.1016/j.rec.2022.07.002. View

15.

Chuang M, Manning W . Pitfalls in comparison of left ventricular mass measurements by echocardiography and cardiovascular magnetic resonance imaging. Nephrol Dial Transplant. 2006; 21(9):2668. DOI: 10.1093/ndt/gfl318. View

16.

Ni M, Li Y, Wei J, Song Z, Wang H, Yao J . Increased Ca Transient Underlies RyR2-Related Left Ventricular Noncompaction. Circ Res. 2023; 133(2):177-192. DOI: 10.1161/CIRCRESAHA.123.322504. View

17.

Zhang J, Jiang M, Zheng C, Liu H, Guo Y, Xie X . Evaluation of isolated left ventricular noncompaction using cardiac magnetic resonance tissue tracking in global, regional and layer-specific strains. Sci Rep. 2021; 11(1):7183. PMC: 8010120. DOI: 10.1038/s41598-021-86695-0. View

18.

Cabrera-Romero E, Ochoa J, Barriales-Villa R, Bermudez-Jimenez F, Climent-Paya V, Zorio E . Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives. J Am Coll Cardiol. 2024; 83(17):1640-1651. DOI: 10.1016/j.jacc.2024.02.036. View

19.

Groeneweg J, Van der Heijden J, Dooijes D, van Veen T, van Tintelen J, Hauer R . Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management. Neth Heart J. 2014; 22(7-8):316-25. PMC: 4099433. DOI: 10.1007/s12471-014-0563-7. View

20.

Cambon-Viala M, Gerard H, Nguyen K, Richard P, Ader F, Pruny J . Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of Noncompaction. J Card Fail. 2021; 27(6):677-681. DOI: 10.1016/j.cardfail.2021.01.007. View